Surveillance of invasive pneumococcal disease in Europe, 2010
In 2010, a new enhanced surveillance system for invasive pneumococcal disease was established in the European Union, coordinated by ECDC, and this report describes the results of the first year of data collection (2010 data). The main aim is to provide information on the epidemiological trends and morbidity caused by the circulating S. pneumoniae serotypes, antimicrobial susceptibility and certain other epidemiological features of invasive pneumococcal disease.
In 2010, 21 565 cases of invasive pneumococcal disease were reported in 26 EU/EEA countries. The highest notification rates are among children under one year (18.54 per 100 000) and adults of 65 years or above (15.59 per 100 000). Meningitis was the most common clinical presentation reported among children under one year while pneumonia/septicaemia was the most frequent presentation for all other age groups.
ECDC/EFSA joint report: Avian inﬂuenza overview October 2016–August 2017
The A(H5N8) highly pathogenic avian inﬂuenza (HPAI) epidemic occurred in 29 European countries in 2016/2017 and has been the largest ever recorded in the EU in terms of number of poultry outbreaks, geographical extent and number of dead wild birds.Read more
Influenza virus characterisation, Summary Europe, July 2017
In the course of the 2016–17 influenza season, nearly 146 000 influenza detections have been reported across the WHO European Region.Read more
Gonococcal antimicrobial susceptibility surveillance in Europe, 2015
The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) follows a decentralised and centralised testing model. In 2015, 24 EU/EEA Member States participated in Euro-GASP, 17 through decentralised testing.Read more